ERBB2 and endometrial cancer: HER2 amplification is found in about 12% of endometrial cancers, and HER2 overexpression by IHC staining was present in 44% of tumors analyzed in the GOG 177 trial, with the highest amplification in high-grade serous and clear-cell cancers [134,135].